Amy Krambeck, MD, highlights 6 studies in BPH and urinary stones being presented at the 2022 American Urological Association Annual Meeting.
In this video, Amy Krambeck, MD, discusses 6 studies in BPH and urinary stones being presented at the 2022 American Urological Association Annual Meeting. Krambeck is a professor of Urology, Department of Urology, Northwestern University, Feinberg School of Medicine.
The following 6 abstracts are previewed:
1. LBA01-02 (Morsy, et al):Efficacy of Low-Power Thulium Laser Enucleation of Prostate Larger Than 80 Grams
2. LBA01-05 (Beltran, et al):Surgical Treatment of Lower Urinary Tract Symptoms Due to Benign Prostatic Enlargement By Holmium Laser Enucleation of the Prostate Versus Transurethral Resection of the Prostate And Open Adenomectomy
3. LBA01-06 (Amparore, el):Long Term Follow-Up of an International Multicenter Prospective Study in Application of Temporary Implantable Nitinol Device (iTind) in Men With Lower Urinary Tract Symptoms for BPH
4. LBA02-04 (Yang, et al): Effect of Extracorporeal Shock Wave Lithotripsy Combined With Extracorporeal Physical Vibration Lithotripsy in the Treatment of Patients With Ureteral Calculi
5. LBA02-08 (Harper, et al): Risk Factors for Increased Stent-Associated Symptoms Following Ureteroscopy for Urinary Stones: Results From the Urinary Stone Disease Research Network (USDRN) Stents Study
6. LBA02-10 (Mookerji, et al): Assessing the Risks of A Positive Urine Culture in Uncomplicated Renal Colic Patients
Ra223 plus SABR does not delay progression of oligometastatic HSPC
October 3rd 2024"The addition of radium-223 to SABR metastasis-directed therapy in low-volume bone-metastatic hormone-sensitive prostate cancer does not delay progression of disease in the RAVENS study," said Ana Kiess, MD, PhD.